All Practice Exams

100+ Free BCNP Practice Questions

Pass your Board Certified Nuclear Pharmacist exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free
1 / 100
Question 1
Score: 0/0

Per 10 CFR 20.1201, what is the annual occupational dose limit (TEDE) for adult radiation workers?

A
B
C
D
to track
2026 Statistics

Key Facts: BCNP Exam

100

Total Questions

BPS

500

Passing Scaled Score

Range 200-800

27%

Largest Domain Weight

Handling of Radioactive Materials

4,000 hrs

Required Experience

Nuclear pharmacy within 7 years

$600

Initial Exam Fee

BPS

NRC

Recognized Credential

Authorized Nuclear Pharmacist

The BCNP (Board Certified Nuclear Pharmacist) exam is administered by BPS and consists of 100 multiple-choice items with a passing scaled score of 500 (range 200-800). Candidates need a PharmD or BS Pharmacy plus 4,000 hours of nuclear pharmacy practice within the past 7 years. The exam fee is $600 initial / $300 retake. The largest domain is Handling of Radioactive Materials at 27%. The credential is recognized by the US NRC as a qualifying credential for the Authorized Nuclear Pharmacist designation.

Sample BCNP Practice Questions

Try these sample questions to test your BCNP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1When ordering a Mo-99/Tc-99m generator, which factor MOST directly determines the calibration time the manufacturer should use?
A.The pharmacy's first scheduled patient elution time
B.The shipping carrier's expected delivery window
C.The state radiation control board curfew
D.The half-life of Tc-99m
Explanation: Generator calibration time is selected so that activity is at the contracted level when the pharmacy needs to elute for first dispensing. Manufacturers calibrate based on the pharmacy's preferred elution time so peak Tc-99m activity is available when needed, accounting for Mo-99 decay (T1/2 ~66 h).
2A pharmacy receives a radiopharmaceutical shipment. Per 10 CFR 20.1906, within what time frame must the package be surveyed for external radiation and removable contamination if it is labeled Yellow-II or Yellow-III?
A.Within 1 hour of receipt during normal working hours, or 3 hours if received after-hours
B.Within 3 hours of receipt during normal working hours, or by the beginning of the next workday if received after-hours
C.Within 8 hours regardless of receipt time
D.Within 24 hours of receipt
Explanation: 10 CFR 20.1906 requires monitoring external surface dose rate and removable contamination for packages labeled Radioactive Yellow-II or Yellow-III as soon as practicable, not later than 3 hours after receipt during normal working hours, or no later than 3 hours from the beginning of the next working day if received after working hours.
3What is the trigger level (removable contamination) on a received radioactive package above which the licensee must immediately notify the NRC and the carrier?
A.22 dpm/cm^2 (0.0037 Bq/cm^2)
B.220 dpm/cm^2 (0.037 Bq/cm^2) for beta/gamma emitters
C.6,600 dpm/cm^2 (1.1 Bq/cm^2) for beta/gamma emitters
D.22,000 dpm/100 cm^2 for alpha emitters only
Explanation: Per 10 CFR 20.1906(d)(1), removable surface contamination exceeding 6,600 dpm/cm^2 (22,000 dpm/100 cm^2 = 22 Bq/cm^2 for beta/gamma) requires immediate notification by phone and telegram/mailgram/facsimile of the final delivering carrier and the NRC Operations Center.
4Which DOT label is required when the transport index (TI) is greater than 1 but not exceeding 10, and the surface dose rate exceeds 0.5 mSv/h but not 2 mSv/h?
A.Radioactive White-I
B.Radioactive Yellow-II
C.Radioactive Yellow-III
D.Empty Radioactive label
Explanation: DOT classifies packages: White-I (TI 0, surface <=0.005 mSv/h), Yellow-II (TI <=1, surface <=0.5 mSv/h), Yellow-III (TI <=10, surface <=2 mSv/h). Therefore TI>1 with surface >0.5 mSv/h requires Yellow-III labeling. Higher than 10 TI requires exclusive use shipment.
5USP <825> classifies the radiopharmaceutical processing area where sterile compounding occurs as which environment?
A.ISO Class 5 primary engineering control within at least an ISO Class 8 buffer area
B.ISO Class 7 primary engineering control within an unclassified ancillary area
C.ISO Class 5 primary engineering control within an unclassified containment ventilated enclosure
D.Open bench in a low-particulate room
Explanation: USP <825> requires sterile radiopharmaceutical compounding in an ISO Class 5 primary engineering control (PEC) located within at least an ISO Class 8 buffer area or, for limited durations, in an SCA following the chapter's specific allowances. This protects sterility while allowing radiation safety design.
6What is the physical half-life of Tc-99m?
A.2.83 days
B.13.2 hours
C.6.01 hours
D.67 hours
Explanation: Tc-99m has a physical half-life of approximately 6.01 hours and decays by isomeric transition to Tc-99 emitting a 140 keV gamma photon, which is ideal for gamma camera imaging.
7A unit dose of Tc-99m sestamibi calibrated for 0900 contains 30 mCi. The patient's appointment is delayed and the dose will be administered at 1500 (6 hours later). What activity remains?
A.7.5 mCi
B.10 mCi
C.15 mCi
D.20 mCi
Explanation: Tc-99m has a 6-hour half-life. Six hours after calibration equals one half-life, so activity is reduced by 50%. 30 mCi x 0.5 = 15 mCi remaining at 1500.
8Per 10 CFR 35.204, the Mo-99 breakthrough limit in an eluate of a Mo-99/Tc-99m generator is which of the following at administration?
A.0.15 kBq Mo-99 per MBq Tc-99m (0.15 microCi/mCi)
B.1.5 kBq Mo-99 per MBq Tc-99m (1.5 microCi/mCi)
C.0.015 kBq Mo-99 per MBq Tc-99m (0.015 microCi/mCi)
D.5.0 kBq Mo-99 per MBq Tc-99m
Explanation: 10 CFR 35.204 limits Mo-99 to 0.15 kBq per MBq of Tc-99m (0.15 microCi Mo-99 per mCi Tc-99m) at the time of administration. The licensee must measure Mo-99 concentration on each eluate of the first elution of each generator.
9During radiochemical purity testing of Tc-99m MDP using ITLC-SG with acetone, where does free Tc-99m pertechnetate migrate?
A.Stays at the origin (Rf ~0)
B.Migrates to the solvent front (Rf ~1)
C.Stays at the midpoint (Rf ~0.5)
D.Migrates only with addition of saline
Explanation: In ITLC-SG with acetone solvent, free Tc-99m pertechnetate is highly soluble and migrates with the solvent to the front (Rf ~1.0), while bound Tc-99m MDP and hydrolyzed-reduced (colloidal) Tc-99m remain at the origin. This separates free pertechnetate impurity from the bound product.
10What dose calibrator quality control test verifies the instrument's response is independent of the activity being measured?
A.Constancy
B.Accuracy
C.Linearity
D.Geometry
Explanation: Linearity testing verifies the dose calibrator's response across the range of activities measured (typically performed quarterly using decay or shield methods). Constancy is daily, accuracy is annual using NIST-traceable standards, and geometry verifies volume independence at installation.

About the BCNP Exam

Specialty certification for pharmacists in nuclear/radiopharmacy practice. The BCNP validates expertise in radiopharmaceutical procurement and storage, kit reconstitution and radiolabeling QC, aseptic technique per USP <797> and <825>, patient-specific dose preparation and decay calculations, NRC regulatory compliance (10 CFR 35), and the Authorized Nuclear Pharmacist scope of practice. The credential is recognized by the US Nuclear Regulatory Commission as a qualifying pathway for the Authorized Nuclear Pharmacist designation.

Questions

100 scored questions

Time Limit

Per BPS scheduling

Passing Score

Scaled 500 (200-800)

Exam Fee

$600 initial / $300 retake (BPS)

BCNP Exam Content Outline

20%

Procurement and Storage

Procurement, receipt, storage, decay-in-storage, generator handling

27%

Handling of Radioactive Materials

Kit reconstitution, radiolabeling QC, aseptic technique, dose preparation

12%

Patient Care

Patient assessment, counseling, post-procedure precautions, I-131 release

12%

Diagnostic and Therapeutic Interventions

SPECT, PET, theranostic agent selection and verification

14%

Patient, Occupational, and Public Safety

ALARA, dose limits, surveys, contamination control, transport

15%

Practice Management

10 CFR 35 license types, written directives, recordkeeping, reportable events

How to Pass the BCNP Exam

What You Need to Know

  • Passing score: Scaled 500 (200-800)
  • Exam length: 100 questions
  • Time limit: Per BPS scheduling
  • Exam fee: $600 initial / $300 retake

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

BCNP Study Tips from Top Performers

1Master decay calculations for common radiopharmaceuticals: Tc-99m (t½ = 6.02 hr), F-18 (109.8 min), I-131 (8.02 days), Lu-177 (6.65 days), Ga-68 (68 min)
2Know NRC 10 CFR 35 license types: 35.100 (uptake/dilution), 35.200 (imaging/localization), 35.300 (therapeutic), 35.400-490 (brachytherapy), 35.500 (sealed sources for diagnosis), 35.600 (Rb-82 generators)
3Memorize USP <825> requirements specific to radiopharmaceuticals — categories of operations, BUDs, environmental controls, personnel competencies
4Understand Mo-99/Tc-99m generator operations: breakthrough testing (Mo-99 contamination ≤0.15 µCi per mCi Tc-99m), Al³⁺ breakdown testing, elution efficiency
5Complete at least 100 practice questions before scheduling your exam

Frequently Asked Questions

Who is eligible for the BCNP exam?

Eligibility requires a PharmD or BS Pharmacy degree, an active pharmacist license, and 4,000 hours of documented nuclear pharmacy practice within the past 7 years. The credential is recognized by the US Nuclear Regulatory Commission as a qualifying pathway for Authorized Nuclear Pharmacist designation under 10 CFR 35.

What is the BCNP exam structure?

The BCNP consists of 100 multiple-choice items with a passing scaled score of 500 (on a 200-800 scale). The fee is $600 for the initial exam and $300 for retakes. Six content domains weight the exam: Procurement/Storage (20%), Handling of Radioactive Materials (27%), Patient Care (12%), Diagnostic/Therapeutic Interventions (12%), Safety (14%), and Practice Management (15%).

What is the most heavily weighted BCNP domain?

Handling of Radioactive Materials carries the largest weight at 27%. This domain covers kit reconstitution, radiolabeling quality control (including paper chromatography and Rf value interpretation), aseptic technique per USP <797> and <825>, patient-specific dose preparation, and radioactive decay calculations.

Does BCNP qualify me for NRC Authorized Nuclear Pharmacist status?

Yes. The US Nuclear Regulatory Commission recognizes BCNP as a qualifying credential for the Authorized Nuclear Pharmacist (ANP) designation under 10 CFR 35.55. ANP status is required for pharmacists who handle byproduct material for medical use.

How should I study for the BCNP exam?

Plan 60-100 hours over 10-14 weeks. Focus heaviest on Handling of Radioactive Materials (27%) and Procurement/Storage + Practice Management (35% combined) — together these are nearly two-thirds of the exam. Master USP <825>, NRC 10 CFR 35 license types, decay calculations, and theranostic dose verification.